Servier Affaires Medicales
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$229Kgeneral payments (2019-2025)
$109Kresearch payments (2019-2025)
54clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Dan Douer | New York, NY | Hematology (Internal Medicine) | $37,299.93 |
| Courtney Dinardo | Houston, TX | Hematology & Oncology | $23,467.18 |
| Joshua Zeidner | Chapel Hill, NC | Hematology & Oncology | $20,731.00 |
| Patrick Wen | Boston, MA | Neurology (Psychiatry & Neurology) | $19,692.21 |
| Vanita Aroda | Boston, MA | Endocrinology, Diabetes & Metabolism | $18,500.00 |
| Timothy Cloughesy | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $17,332.22 |
| David Rubinow | Chapel Hill, NC | Psychiatry | $15,554.53 |
| Vaibhav Sahai | Ann Arbor, MI | Medical Oncology | $11,701.00 |
| Lewis Silverman | New York, NY | Pediatric Hematology-Oncology | $9,875.80 |
| Scott Howard | Memphis, TN | Pediatric Hematology-Oncology | $9,378.64 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.